Qube Research & Technologies LTD Abb Vie Inc. Put Options Transaction History

Qube Research & Technologies LTD

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$163.84 - $199.33 $7.03 Million - $8.55 Million	-42,900 Reduced 17.88%	197,000 $38.9 Million
Q2 2024 Aug 14, 2024	BUY	$154.79 - $180.76 $495,328 - $578,432	3,200 Added 1.35%	239,900 $41.1 Million
Q1 2024 May 14, 2024	BUY	$159.82 - $182.1 $26 Million - $29.6 Million	162,600 Added 219.43%	236,700 $43.1 Million
Q4 2023 Feb 13, 2024	BUY	$137.6 - $154.97 $10.2 Million - $11.5 Million	74,100 New	74,100 $11.5 Million
Q1 2023 May 15, 2023	BUY	$144.61 - $166.54 $3.62 Million - $4.16 Million	25,000 Added 100.0%	50,000 $7.97 Million
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $3.46 Million - $4.15 Million	25,000 New	25,000 $4.04 Million
Q1 2022 May 09, 2022	BUY	$131.98 - $163.75 $3.3 Million - $4.09 Million	25,000 New	25,000 $4.05 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.